About Index Trending news
Analyze
Pricing
Mersana Therapeutics

Mersana Therapeutics

Work at Mersana Therapeutics? Add yourself to this profile

Mersana Therapeutics

Rewriting the rules for immunoconjugate therapies.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co HubSpot HubSpot nuTonomy nuTonomy Biogen Biogen General Catalyst General Catalyst Harvard University Harvard University

Companies in the same industry

Savara Pharmaceuticals Savara Pharmaceuticals BrainStorm Cell Therapeutics BrainStorm Cell Therapeutics Neos Therapeutics, Inc. Neos Therapeutics, Inc. AC Immune AC Immune SyntheX SyntheX Tioma Therapeutics Tioma Therapeutics Proclara Biosciences Proclara Biosciences Therachon AG Therachon AG Abeona Therapeutics Abeona Therapeutics Seattle Genetics Seattle Genetics

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
28 Jun 2017
$75,000,000
IPO

VC-backed Mersana Therapeutics debuts IPO

PE Hub
16 Jun 2016
$33,000,000
Venture capital (Series C)
Wellington Management, Rock Springs Capital, Arrowpoint Partners, +3

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

biospace
+1